The Russian Ministry of Health has approved a surfactant-BL product for the treatment of respiratory distress syndrome in adults

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1395, 2003-01, pp. : 22-22

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Lucinactant: a novel synthetic surfactant for the treatment of respiratory distress syndrome

By Donn Steven M  

Expert Opinion on Investigational Drugs, Vol. 14, Iss. 3, 2005-03 ,pp. : 329-334

Informa Healthcare

Access to resources Recommend Favorite

Acute respiratory distress syndrome following treatment for babesiosis

By Jr Ryland P Byrd   Roy Thomas M  

Expert Opinion on Pharmacotherapy, Vol. 3, Iss. 11, 2002-11 ,pp. : 1541-1542

Informa Healthcare

Access to resources Recommend Favorite

Current Perspectives on the Drug Treatment of Neonatal Respiratory Distress Syndrome

By Sweet D.G.   Halliday H.L.  

Pediatric Drugs, Vol. 1, Iss. 1, 1999-01 ,pp. : 19-30

Adis International

Access to resources Recommend Favorite

Pharmacotherapy for Prevention and Treatment of Acute Respiratory Distress Syndrome: Current and Experimental Approaches

By Bosma Karen J.   Taneja Ravi   Lewis James F.  

Drugs, Vol. 70, Iss. 10, 2010-07 ,pp. : 1255-1282

Adis International

Access to resources Recommend Favorite

Nitric oxide for the treatment of preterm infants with respiratory distress syndrome

By Dani Carlo   Pratesi Simone  

Expert Opinion on Pharmacotherapy, Vol. 14, Iss. 1, 2013-01 ,pp. : 97-103

Informa Healthcare

Access to resources Recommend Favorite